| Code | Description | Claims | Beneficiaries | Total Paid |
| 95144 |
|
2,748 |
514 |
$973K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
12,730 |
9,345 |
$569K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
9,907 |
7,195 |
$494K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
9,106 |
6,584 |
$212K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
510 |
390 |
$51K |
| 95004 |
Percutaneous tests with allergenic extracts, immediate type reaction |
551 |
516 |
$48K |
| 95165 |
Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials |
654 |
517 |
$21K |
| 99349 |
|
36 |
36 |
$88.80 |